Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Nabil Abdelfadil Elserwy"'
Autor:
Nabil Abdelfadil Elserwy, Esam Elden Lotfy, Mohamad Ashraf Fouda, Medhat Ibrahim Mahmoud, Ahmed Farouk Donia, Mohamed Elsayed Mashaly, Mohamed Hamed Abbas, Mohamed Megahed Abuelmagd, Rasha Kamal Abouelenein, Mabrouk Ibrahim Ismail, Mohamed Adel Bakr
Publikováno v:
Saudi Journal of Kidney Diseases and Transplantation, Vol 28, Iss 3, Pp 579-588 (2017)
The newer and potent immunosuppressive agents have successfully reduced the risk of rejection after kidney transplantation, but the development of cardiovascular diseases, infections, and malignancy is major factors limiting their success. Posttransp
Externí odkaz:
https://doaj.org/article/93a9132136b14f5a941d1acb19d259d0
Autor:
Ayman Maher Nagib, Zoheer A Fayyad, Nabil Abdelfadil Elserwy, Mohamed Abdel Monem, Mahmoud Mohamed Khaled, Zakaria Zakaria, Amro M Mahmoud, Khaled A Atea, Ahmed S Draz, Ahmed Y Mostafa, Mohamed A Hammad, Medhat A Halim, Prasad Nair, Mohammed M Abuelmagd, Mohamed Shaker, Mohamed E Ameenn, Mohammed Adel, Tarek Mahmoud, Osama Gheith, Ahmed K Alqallaf, Torki Al-Otaibi, Ahmad Abbas, Hasaneen H Aboatya, Ahmed F Atta
Publikováno v:
Clinical Transplantation
Introduction COVID‐19 is an ongoing pandemic with high morbidity and mortality and with a reported high risk of severe disease in kidney transplant recipients (KTR). Aim We aimed to report the largest number of COVID‐19‐positive cases in KTR in
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a5af02d5f2856d9ebc026a895eaa09f3
https://pubmed.ncbi.nlm.nih.gov/33768630
https://pubmed.ncbi.nlm.nih.gov/33768630
Autor:
Mohamed Elsayed Mashaly, Rasha Kamal Abouelenein, Esam Elden Lotfy, medhat ibrahim mahmoud, Nabil Abdelfadil Elserwy, Mabrouk I. Ismail, Ahmed Farouk Donia, Mohamed Hamed Abbas, Mohamed Megahed Abuelmagd, Mohamed A. Bakr, mohamad ashraf fouda
Publikováno v:
Saudi Journal of Kidney Diseases and Transplantation, Vol 28, Iss 3, Pp 579-588 (2017)
The newer and potent immunosuppressive agents have successfully reduced the risk of rejection after kidney transplantation, but the development of cardiovascular diseases, infections, and malignancy is major factors limiting their success. Posttransp
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::95ffc58c99cfadca1c6ff99290d8909b
http://www.sjkdt.org/article.asp?issn=1319-2442
http://www.sjkdt.org/article.asp?issn=1319-2442
Autor:
Rasha Kamal, Abouelenein, Ayman Fathi, Refaie, Yaser A, Alhendy, Amir M, Al Okily, Nabil Abdelfadil, Elserwy, Mohamed Elsayed, Mashaly, Mohamed Hamed, Abbas, Mohamed Adel, Bakr
Publikováno v:
Experimental and clinical transplantation : official journal of the Middle East Society for Organ Transplantation.
The goal when treating patients with end-stage renal disease is to increase patient survival and to provide a better quality of life, both of which can be achieved by kidney transplant. Identifying problems associated with kidney transplant is an ess
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::5aac742dd4a0f565fa1cdad1bbff5a65
https://pubmed.ncbi.nlm.nih.gov/30501588
https://pubmed.ncbi.nlm.nih.gov/30501588